| # | Drug | Count |
|---|---|---|
| 0 | CLOZAPINE | 425 |
| 1 | QUETIAPINE | 235 |
| 2 | ARIPIPRAZOLE | 216 |
| 3 | LITHIUM CARBONATE | 216 |
| 4 | RISPERIDONE | 210 |
| 5 | OLANZAPINE | 202 |
| 6 | AMISULPRIDE | 190 |
| 7 | ARIPIPRAZOLE ORAL | 180 |
| 8 | ARIPIPRAZOLE ORALLY DISINTEGRATING | 180 |
| 9 | CITALOPRAM | 172 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TRIFLUOPERAZINE HYDROCHLORIDE | 40 | 0.3175 |
| 1 | PERPHENAZINE | 150 | 0.0719 |
| 2 | ZIPRASIDONE HCL | 111 | 0.0417 |
| 3 | HALOPERIDOL DECANOATE | 66 | 0.0379 |
| 4 | THIORIDAZINE HYDROCHLORIDE | 2 | 0.0357 |
| 5 | AMISULPRIDE | 190 | 0.0310 |
| 6 | LOXAPINE | 123 | 0.0308 |
| 7 | ZIPRASIDONE | 84 | 0.0233 |
| 8 | ASENAPINE MALEATE | 151 | 0.0174 |
| 9 | LITHIUM CARBONATE | 216 | 0.0126 |
| # | Drug class | Count |
|---|---|---|
| 0 | Atypical Antipsychotic [EPC] | 530 |
| 1 | Dopamine-2 Receptor Antagonist [EPC] | 190 |
| 2 | Typical Antipsychotic [EPC] | 158 |
| 3 | Phenothiazine [EPC] | 150 |
| 4 | Serotonin Reuptake Inhibitor [EPC] | 143 |
| 5 | Benzodiazepine [EPC] | 81 |
| 6 | Mood Stabilizer [EPC] | 63 |
| 7 | Anti-epileptic Agent [EPC] | 59 |
| 8 | Nonsteroidal Anti-inflammatory Drug [EPC] | 30 |
| 9 | HMG-CoA Reductase Inhibitor [EPC] | 29 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Dopamine-2 Receptor Antagonist [EPC] | 190 | 0.0244 |
| 1 | Typical Antipsychotic [EPC] | 158 | 0.0063 |
| 2 | Phenothiazine [EPC] | 150 | 0.0050 |
| 3 | Serotonin Reuptake Inhibitor [EPC] | 143 | 0.0016 |
| 4 | Atypical Antipsychotic [EPC] | 530 | 0.0012 |
| 5 | Aldehyde Dehydrogenase Inhibitor [EPC] | 1 | 0.0009 |
| 6 | Monoamine Oxidase Inhibitor [EPC] | 2 | 0.0006 |
| 7 | Provitamin D2 Compound [EPC] | 10 | 0.0003 |
| 8 | Mood Stabilizer [EPC] | 63 | 0.0003 |
| 9 | Anti-epileptic Agent [EPC] | 59 | 0.0003 |